These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The development of an optimized autologous blood donation program. Rock G; Bormanis J; Neurath D Transfus Apher Sci; 2005 Nov; 33(3):325-31. PubMed ID: 16242382 [TBL] [Abstract][Full Text] [Related]
46. Changing blood transfusion practice in elective joint arthroplasty: a nursing initiative. Marcinkowski K; McDonald B Nurs Prax N Z; 2006 Nov; 22(3):15-21. PubMed ID: 17375484 [TBL] [Abstract][Full Text] [Related]
47. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results. Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258 [TBL] [Abstract][Full Text] [Related]
49. [Secondary costs of the disposition of preoperatively withdrawn autologous blood preserves]. Diekamp U Beitr Infusionsther Transfusionsmed; 1994; 32():517-9. PubMed ID: 9480155 [TBL] [Abstract][Full Text] [Related]
50. [Intraoperative autotransfusion at a community hospital]. Hoffmann I; Bogosyan S; Götz E Beitr Infusionther Klin Ernahr; 1987; 18():76-82. PubMed ID: 3440009 [No Abstract] [Full Text] [Related]
51. Primer on blood salvage: implications for the hospital pharmacist. Bardas SL Hosp Pharm; 1994 Dec; 29(12):1098, 1100-3. PubMed ID: 10172170 [TBL] [Abstract][Full Text] [Related]
52. Technology, medicine & health, Part 4. Technological cancer: its causes & treatment. Davidson SN Healthc Forum J; 1995; 38(2):52-8. PubMed ID: 10172234 [No Abstract] [Full Text] [Related]
53. Economic analysis of an intraoperative cell salvage service. Szpisjak DF; Potter PS; Capehart BP Anesth Analg; 2004 Jan; 98(1):201-205. PubMed ID: 14693619 [TBL] [Abstract][Full Text] [Related]
54. A device category economic model of electrosurgery technologies across procedure types: a U.S. hospital budget impact analysis. Ferko N; Wright GWJ; Syed I; Naoumtchik E; Tommaselli GA; Gangoli G J Med Econ; 2021; 24(1):524-535. PubMed ID: 33851557 [TBL] [Abstract][Full Text] [Related]
55. The iterative use of economic evaluation as part of the process of health technology assessment. Sculpher M; Drummond M; Buxton M J Health Serv Res Policy; 1997 Jan; 2(1):26-30. PubMed ID: 10180650 [TBL] [Abstract][Full Text] [Related]
56. Intraoperative autotransfusion: an old idea comes of age. Allen GJ Surg Technol; 1992 Jan; 24(1):8-13. PubMed ID: 10118527 [No Abstract] [Full Text] [Related]
58. Cured Today, Ill Tomorrow: A Method for Including Future Unrelated Medical Costs in Economic Evaluation in England and Wales. Perry-Duxbury M; Asaria M; Lomas J; van Baal P Value Health; 2020 Aug; 23(8):1027-1033. PubMed ID: 32828214 [TBL] [Abstract][Full Text] [Related]
59. Clinical and economic assessment of new surgical technologies. Fendrick AM J Natl Cancer Inst Monogr; 1995; (19):57-60. PubMed ID: 7577207 [No Abstract] [Full Text] [Related]
60. [Methods p6 economizing donor blood. Appendix. Recommendations for the adoption of methods of economizing donor blood]. Klin Anasthesiol Intensivther; 1993; 43():189-206. PubMed ID: 8421380 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]